John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 4,600 shares at $75.50 ($347K) on 2015-06-25, disclosed to the SEC on 2015-06-30.
Open-market sale of $347k KYTH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |